Workflow
RUCONEST®
icon
搜索文档
Pharming Group announces third quarter 2026 revenues above market expectations
Globenewswire· 2026-10-22 13:00
Third quarter 2026 total revenues increase by 21% to approximately US$117.6 million, compared to third quarter 2025Third quarter 2026 total operating expenses of approximately US$74.6 million, in line with third quarter 2025Tightened 2026 total revenue guidance to US$380 million - US$390 million from prior US$375 million - US$395 millionFull third quarter financial results and business update brought forward to October 27, 2026; conference call and webcast for analysts and investors to follow at 13:30 CET/0 ...